Recent Technological Advancements In Health Care Sector Propel Growth Of MRI Safe Implantable Defibrillator Devices Market

The global demand for MRI safe implantable defribrillator devices witnessed a slight fall in the first quarter of 2020 due to the spread of Covid-19 pandemic. Major attention was shifted towards preventing the ongoing crisis leading to neglecting further developments in this market.

However, as the cases are getting down in 2021, incessant efforts of the market players are helping themto recuperate their market position.

In 2021, smart-phone connected heart devices are among the top innovations which is globally attracting the people suffering from cardiac diseases. Pacemakers and other implanted heart devices that can be connected to a patient’s mobile phone is acting as the most impresive breakthrough in healthcare technologies especially in Covid-19 phase for providing mental and physical peace.

For detailed insights on enhancing your product footprint, request for a sample here –

Remote monitoring of cardiac patients is a recent trend as it is allowing the heart patients to receive expert medical guidance from their physicians while staying at home or travellinginstead of visiting the hospital premises.

As cyberattacks poses a threat to patient’s data securities, manufacturers in 2020 launched many advanced MRI safe implantable defibrillators with high security controls including access restrictions to protect integrity of device functionalities to create considerable attraction among the users.

At present, smart-innovation is acting as a key factor for promoting the growth of MRI safe implantable defibrillators. Getinge and Boston Corporation are among the market players delivering innovation with their improved outcomes and developments.

The market players in 2021 are focusing more on developing innovative devices to catch global attention. Technological advancements, new product launches, research and develoments, acquisitions, expansions and collaborations continue to be the highly adopted strategies since 2020.

For instance, Boston Corporation launched “DirectSense Technology”, a new tool for monitoring the effect of radiofrequency energy delivery during cardiac ablation procedures on June, 2020. This technology provides data on the impedanceto measure the abilityof tissues to respond to RF energy before physicians deliver therapy.

The introduction of this technology has added immense progress to this market by attracting global heart patients towards it.

Further, it has also entered into a definitive agreement to acquire Preventice Solutions, a company that offers a portfolio of mobile cardiac health solutions on 21st January, 2021 with an upfront cash payment of$925 millions and upto an additional $300 million in a potential commercial milestone payment. The portfolio includes BodyGuardian family of remote, wearable cardiac monitorsetc for adult as well as paediatric patients.

To receive extensive list of important regions, ask for TOC here –

In addition to that, Medtronic Corporation on 8th October, 2020 launched  “Azure”, a pacemaker that links patient’s smartphones and tablets offering improved longevity so that patients need fewer device replacements and allow them to have MRI (magnetic resonance imaging) scans in either  1.5 or 3 Tesla machines.

This pacemaker comes with Bluesync technology that can directly communicate with a patient’s smartphone or  tablet. This latest addition is designed to accurately detect and reduce the likelihood of atrial fabrication and enable automatic and secure wireless communication via bluetooth low energy and remote monitoring through Medtronic CareLink Network, providing more timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time.

Security controls are implemented in such devices to protect patient’s data. Azure is  becoming the mostly preferred pacemaker in 2021.

Global MRI Safe Implantable Defibrillator Devices Market: Overview

Cardiac defibrillator which were invented to deliver shock in order to control the abnormal heartbeat rhythms were proved to be a valuable device as it can prevent sudden death.

MRI which is one of the most important diagnosis test for various problems like neurology, orthopedics, and cardiology found it difficult to test a person implanted with defibrillator as it can cause harm to it, even damaging the myocardium, thus the invention of MRI safe implantable defibrillator devices gained popularity with the healthcare sector with no time.

Flexibility of this defibrillator during MRI test, is the leading factor that is making the people implanted with conventional defibrillator shift to MRI safe implantable defibrillator devices market, as there are certain risk associated with the former during a MRI test.

Factors such as increase in geriatric population, rise in cardiac diseases and product advancement are promoting the growth of MRI safe implantable defibrillator devices. Increase in awareness among patient about their safety and various marketing campaigns by various manufacturers are contributing to the growth of the demand.

For critical insights on this market, request for methodology here –

However, the price tag of these devices is expected to deter the growth of the market during the forecast period. Apart from the price tag, absence of skilled professionals in emerging countries is also anticipated to pull down the market growth.

Cardiac defibrillator is a battery powered pulse generator used to correct the abnormal heart rhythms by delivering an electric shock. It is very valuable device in preventing sudden deaths. For several years in the past, MRI was not allowed in patients having implanted devices such as cardiac defibrillator or pacemakers as it may alter pacing properties or even damage myocardium, thus might be raising concerns for clinicians.

As, MRI is one of the most useful diagnostic test for patients with various medical problems including cardiology, neurology, orthopaedics etc., therefore the development of MRI safe implantable defibrillator devices helps in solving the problem of risks associated with MRI scans.

Several research in the area proves that nearly two-third of patients implanted with a defibrillator needed an MRI diagnosis within four years of implantation, thereby generating the need of MRI safe implantable defibrillator devices.

The MRI safe implantable defibrillator devices are available as single chambered or dual chambered. These devices are either recognized as MR conditional or MR safe devices. They contain specific hardware and software components specifically tested and officially verified for use under magnetic resonance environment.

MRI Safe Implantable Defibrillator Devices Market: Segmentation

Segmentation by Product Type:

  • Single Chamber Defibrillator
  • Dual Chamber Defibrillator

Segmentation by Modality:

  • MR Conditional Defibrillator
  • MR Safe Defibrillator

Segmentation by End User

  • Hospitals
  • Ambulatory Surgical Centers

MRI Safe Implantable Defibrillator Devices Market Treatment Market: Key Players

Some of the players in the MRI Safe Implantable Defibrillator Devices market includes Medtronic, Boston Scientific Corporation, Abbott, Microport, Biotronik etc.

Pre-Book Right Now for Exclusive Analyst Support –

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Matched content

Editor’s pick

Express Press Release Distribution